News Releases
News Release
Notice Regarding Conclusion of an Exclusive Distribution Agreement for Embolization Agents in the Japanese Market
Asahi Intecc announces that it has entered into an exclusive distribution agreement in Japan for the embolization agent “Nexsphere-F™,” developed and manufactured by NEXTBIOMEDICAL CO., LTD. (hereinafter “Nextbio”) of South Korea.
Click here for details.